Svai Sanford
2023
In 2023, Svai Sanford earned a total compensation of $2.2M as Chief Financial Officer at Rani Therapeutics Holdings, a 9% increase compared to previous year.
Compensation breakdown
| Option Awards | $983,836 |
|---|---|
| Salary | $416,000 |
| Stock Awards | $756,160 |
| Total | $2,155,996 |
Sanford received $983.8K in option awards, accounting for 46% of the total pay in 2023.
Sanford also received $416K in salary and $756.2K in stock awards.
Rankings
In 2023, Svai Sanford's compensation ranked 464th out of 2,647 executives tracked by ExecPay. In other words, Sanford earned more than 82.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 464 out of 2,647 | 83rd |
Division Manufacturing | 267 out of 1,447 | 82nd |
Major group Chemicals And Allied Products | 186 out of 817 | 77th |
Industry group Drugs | 183 out of 783 | 77th |
Industry Pharmaceutical Preparations | 115 out of 555 | 79th |
Source: SEC filing on April 17, 2024.
Sanford's colleagues
We found two more compensation records of executives who worked with Svai Sanford at Rani Therapeutics Holdings in 2023.